{"entity":{"id":"nct03733249","kind":"trial","name":"Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study","aka":[],"tldr":"A phase 1/2 trial of Rivogenlecleucel run by Bellicum Pharmaceuticals, terminated.","summary":"Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study is a phase 1/2 interventional study registered as NCT03733249 by Bellicum Pharmaceuticals, with 187 participants enrolled, started 2017-01. Conditions recorded: Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Primary Immunodeficiency, Anemia, Aplastic, Hemoglobinopathies, Cytopenia, Fanconi Anemia, Diamond Blackfan Anemia, Thalassemia and Anemia, Sickle Cell. Interventions recorded: Rimiducid and rivogenlecleucel.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT03733249","url":"https://clinicaltrials.gov/study/NCT03733249"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["all-leukemia","aml","non-hodgkin-lymphoma","mds"],"sections":[],"technologies":[],"targets":[],"drugs":["rivogenlecleucel"],"companies":["bellicum"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03733249","phase":"1/2","setting":"Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders","sponsor":"Bellicum Pharmaceuticals","enrolled":187,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03733249/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"mds","kind":"cancer","name":"Myelodysplastic syndromes / neoplasms (MDS)","route":"/cancers/mds/"},{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"drug":[{"id":"rivogenlecleucel","kind":"drug","name":"Rivogenlecleucel","route":"/drugs/rivogenlecleucel/"}],"company":[{"id":"bellicum","kind":"company","name":"Bellicum Pharmaceuticals","route":"/companies/bellicum/"}]}}